GPT and acute kidney injury: Patrono et al.23 reported that the use of HOPE for grafts obtained from donation after brain death was associated with a significant reduction in stage 2–3 acute kidney injury and severe post-reperfusion syndrome, a lower incidence of early allograft dysfunction, and a reduced post-transplantation AST and ALT peak.